← Leaderboards
Shunqiang Li
George Washington University
$3,121,300
Attributed
$8,639,618
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,075,035 · 5
By mechanism
U54$8,507,643 · 3
U24$5,680,686 · 1
R01$1,886,706 · 1
Top collaborators
- Li Ding15 shared
- Ramaswamy Govindan11 shared
- Kooresh Isaac Shoghi9 shared
- Cynthia X Ma7 shared
- Joseph J. H. Ackerman5 shared
- Richard Leo Wahl5 shared
- Wenge Zhu3 shared
Most similar at George Washington University
Same institution · by research overlap
- Wenge Zhu$9,139,423
- Cynthia X Ma$3,639,182
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorWashingtonUniversitiesExome SequencingMalignant Breast NeoplasmResponseTranscriptome SequencingMalignant NeoplasmsClinical ResearchEvaluationInstitutesClinical TrialsCancer SubtypesImageResourcesSamplingCollaborationsResearch Project GrantsResearch PersonnelStructureBioinformaticsFundingMedical SchoolsCombined Modality Therapy
Grant awards (28)
Washington University Co-Clinical Imaging Research Resource$645,323
U24 · FY2025 · CA
Regulation of resistance to CDK4/6 inhibitor in breast cancer$633,959
R01 · FY2025 · CA
Washington University Co-Clinical Imaging Research Resource$613,057
U24 · FY2024 · CA
Regulation of resistance to CDK4/6 inhibitor in breast cancer$602,262
R01 · FY2024 · CA
Regulation of resistance to CDK4/6 inhibitor in breast cancer$650,485
R01 · FY2023 · CA
Washington University Co-Clinical Imaging Research Resource$633,278
U24 · FY2023 · CA
Washington University Co-Clinical Imaging Research Resource$665,295
U24 · FY2022 · CA
Washington University PDX Development and Trial Center$521,719
U54 · FY2022 · CA
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models$200,000
U54 · FY2022 · CA
Washington University PDX Development and Trial Center$1,252,124
U54 · FY2021 · CA
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE$624,395
U24 · FY2021 · CA
Washington University PDX Development and Trial Center$119,999
U54 · FY2021 · CA
Washington University PDX Development and Trial Center$1,252,125
U54 · FY2020 · CA
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE$625,517
U24 · FY2020 · CA
Washington University PDX Development and Trial Center$119,999
U54 · FY2020 · CA
Washington University PDX Development and Trial Center$1,248,813
U54 · FY2019 · CA
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE$610,912
U24 · FY2019 · CA
PDX Core$357,425
U54 · FY2019 · CA · contact PI
Washington University PDX Development and Trial Center$120,445
U54 · FY2019 · CA
Washington University PDX Development and Trial Center$120,444
U54 · FY2019 · CA
Washington University PDX Development and Trial Center$54,999
U54 · FY2019 · CA
PDX Core$20,075
U54 · FY2019 · CA · contact PI
PDX Core$20,074
U54 · FY2019 · CA · contact PI
PDX Core$9,167
U54 · FY2019 · CA · contact PI
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE$630,034
U24 · FY2018 · CA
Washington University PDX Development and Trial Center$2,424,750
U54 · FY2017 · CA
PDX Core$665,485
U54 · FY2017 · CA · contact PI
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE$632,875
U24 · FY2017 · CA